Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
201-500
employees, estimated range
Grants
$2.8M
2 grants · CORDIS
Backers
4
Chalmers Ventures, Industrifonden
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 10%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Grant May 2025 $292k — CORDIS
Grant May 2019 $2.5M — CORDIS
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Ahead HealthVenture round $10M · 1 mo ago • 51-200 employees
Early detection of cancer, liver disease and over 500 other diseases. Receive a personal health action plan with full body MRI and blood…
Noah LabsFounded 2022 • 51-200 employees • 3 roles
A breakthrough for heart failure: Noah Labs Ark is a Class IIa Medical Device Software with AI-driven detection of early cardiac…
FidoCureFounded 2018
AI-Enabled Personalized Therapeutics for Canine Cancer. Personalized therapeutics can offer a more hopeful prognosis. FidoCure®, developed…
Numen11-50 employees • 2 roles
Engineering a futurewithout cancer deaths.. Rapid at-homediagnostics.
DELFI DiagnosticsVenture round $225M · 4 yr ago • Founded 2019 • 51-200 employees • 5 roles
FirstLook Lung is a blood-based test that helps identify lung cancer risk before or alongside LDCT, for USPSTF-eligible adults. From DELFI…
DognosisFounded 2020 • 51-200 employees • 1 role
BreathEasy analyses your breath profile, helping your doctor understand your cancer risk. 90.8% sensitivity and 91.3% specificity in a…

Overview

Early detection of cancer starts with knowing who is at risk. Elypta provides the missing dynamic biological signal that unlocks risk testing at scale.

Financials

Total raised
$2.8M
Latest round
Grant
Funding rounds
2
Funding rounds
Round Announced Amount
Grant 2025 $292k Details
Grant 2019 $2.5M Details